Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Patient perspectives on fluticasone-vilanterol versus other corticosteroid combination products for the treatment of asthma.

Bollmeier SG, Prosser TR.

Patient Prefer Adherence. 2016 May 13;10:825-36. doi: 10.2147/PPA.S83946. eCollection 2016. Review.

2.

Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.

Beasley RW, Donohue JF, Mehta R, Nelson HS, Clay M, Moton A, Kim HJ, Hederer BM.

BMJ Open. 2015 Feb 3;5(2):e006131. doi: 10.1136/bmjopen-2014-006131.

3.

Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.

De Vera MA, Sadatsafavi M, Tsao NW, Lynd LD, Lester R, Gastonguay L, Galo J, FitzGerald JM, Brasher P, Marra CA.

Trials. 2014 Dec 13;15:488. doi: 10.1186/1745-6215-15-488.

4.

Effect of electronic prescribing with formulary decision support on medication tier, copayments, and adherence.

Pevnick JM, Li N, Asch SM, Jackevicius CA, Bell DS.

BMC Med Inform Decis Mak. 2014 Aug 28;14:79. doi: 10.1186/1472-6947-14-79.

5.

LABA monotherapy in asthma: an avoidable problem.

Morales DR.

Br J Gen Pract. 2013 Dec;63(617):627-8. doi: 10.3399/bjgp13X675250. No abstract available.

6.

Management of asthma in the elderly patient.

Melani AS.

Clin Interv Aging. 2013;8:913-22. doi: 10.2147/CIA.S33609. Epub 2013 Jul 15. Review.

7.

Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients.

Björnsdóttir US, Gizurarson S, Sabale U.

Int J Clin Pract. 2013 Sep;67(9):904-10. doi: 10.1111/ijcp.12202. Epub 2013 Jun 16. Review.

8.

Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy.

Ruggeri I, Bragato D, Colombo GL, Valla E, Di Matteo S.

Clinicoecon Outcomes Res. 2012;4:375-82. doi: 10.2147/CEOR.S36499. Epub 2012 Dec 5.

9.

Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children.

Elkout H, Helms PJ, Simpson CR, McLay JS.

PLoS One. 2012;7(6):e39130. doi: 10.1371/journal.pone.0039130. Epub 2012 Jun 27.

10.

Stepping down asthma treatment: how and when.

Rogers L, Reibman J.

Curr Opin Pulm Med. 2012 Jan;18(1):70-5. doi: 10.1097/MCP.0b013e32834db017. Review.

11.

Adherence with preventive medication in childhood asthma.

Burgess S, Sly P, Devadason S.

Pulm Med. 2011;2011:973849. doi: 10.1155/2011/973849. Epub 2011 Apr 6.

13.
14.

Outcomes after periodic use of inhaled corticosteroids in children.

Wu AC, Li L, Miroshnik I, Glauber J, Gay C, Lieu TA.

J Asthma. 2009 Jun;46(5):517-22. doi: 10.1080/02770900802468517.

15.

Safety of long-acting beta-agonists: urgent need to clear the air remains.

Beasley R, Martinez FD, Hackshaw A, Rabe KF, Sterk PJ, Djukanovic R.

Eur Respir J. 2009 Jan;33(1):3-5. doi: 10.1183/09031936.00163408. No abstract available.

16.

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.

Aballéa S, Cure S, Vogelmeier C, Wirén A.

Int J Clin Pract. 2008 Dec;62(12):1870-9. doi: 10.1111/j.1742-1241.2008.01895.x. Epub 2008 Sep 17.

Supplemental Content

Support Center